T J Hoerger

Summary

Affiliation: RTI International
Country: USA

Publications

  1. pmc Cost-effectiveness of hepatitis B vaccination in adults with diagnosed diabetes
    Thomas J Hoerger
    RTI International, Research Triangle Park, NC, USA
    Diabetes Care 36:63-9. 2013
  2. pmc Cost-effectiveness of screening for microalbuminuria among African Americans
    Thomas J Hoerger
    RTI International, 3040 Cornwallis Road, PO Box 12194, Research Triangle Park, NC 27709, USA
    J Am Soc Nephrol 23:2035-41. 2012
  3. ncbi request reprint Is glycemic control improving in U.S. adults?
    Thomas J Hoerger
    RTI UNC Center of Excellence in Health Promotion Economics, RTI International, 3040 Cornwallis Rd, P O Box 12194, Research Triangle Park, NC 27709, USA
    Diabetes Care 31:81-6. 2008
  4. ncbi request reprint The impact of diabetes and associated cardiometabolic risk factors on members: strategies for optimizing outcomes
    Thomas J Hoerger
    Research Triangle Institute International, USA
    J Manag Care Pharm 14:S2-14; quiz 15-6. 2008
  5. doi request reprint Using costs in cost-effectiveness models for chronic diseases: lessons from diabetes
    Thomas J Hoerger
    RTI UNC Center of Excellence in Health Promotion Economics, RTI International, Research Triangle Park, North Carolina 27709, USA
    Med Care 47:S21-7. 2009
  6. doi request reprint Improvements in risk factor control among persons with diabetes in the United States: evidence and implications for remaining life expectancy
    Thomas J Hoerger
    RTI International, Research Triangle Park, NC 27709, USA
    Diabetes Res Clin Pract 86:225-32. 2009
  7. doi request reprint A health policy model of CKD: 2. The cost-effectiveness of microalbuminuria screening
    Thomas J Hoerger
    RTI International, Research Triangle Park, NC 27709, USA
    Am J Kidney Dis 55:463-73. 2010
  8. doi request reprint A health policy model of CKD: 1. Model construction, assumptions, and validation of health consequences
    Thomas J Hoerger
    RTI International, Research Triangle Park, NC 27709, USA
    Am J Kidney Dis 55:452-62. 2010
  9. pmc Cost-effectiveness of bariatric surgery for severely obese adults with diabetes
    Thomas J Hoerger
    RTI UNC Center of Excellence in Health Promotion Economics, RTI International, Research Triangle Park, North Carolina, USA
    Diabetes Care 33:1933-9. 2010
  10. pmc A cost-benefit analysis of lipid standardization in the United States
    Thomas J Hoerger
    RTI International, 3040 Cornwallis Road, PO Box 12194, Research Triangle Park, NC 27709, USA
    Prev Chronic Dis 8:A136. 2011

Detail Information

Publications31

  1. pmc Cost-effectiveness of hepatitis B vaccination in adults with diagnosed diabetes
    Thomas J Hoerger
    RTI International, Research Triangle Park, NC, USA
    Diabetes Care 36:63-9. 2013
    ..Partly based on these results, the Advisory Committee on Immunization Practices recently recommended hepatitis B vaccination for people 20-59 years of age with diagnosed diabetes...
  2. pmc Cost-effectiveness of screening for microalbuminuria among African Americans
    Thomas J Hoerger
    RTI International, 3040 Cornwallis Road, PO Box 12194, Research Triangle Park, NC 27709, USA
    J Am Soc Nephrol 23:2035-41. 2012
    ..In summary, these models suggest that screening African Americans for microalbuminuria at either 5- or 10-year intervals is highly cost-effective...
  3. ncbi request reprint Is glycemic control improving in U.S. adults?
    Thomas J Hoerger
    RTI UNC Center of Excellence in Health Promotion Economics, RTI International, 3040 Cornwallis Rd, P O Box 12194, Research Triangle Park, NC 27709, USA
    Diabetes Care 31:81-6. 2008
    ..The purpose of this study was to examine whether glycemic control has improved in recent years among individuals with diagnosed diabetes...
  4. ncbi request reprint The impact of diabetes and associated cardiometabolic risk factors on members: strategies for optimizing outcomes
    Thomas J Hoerger
    Research Triangle Institute International, USA
    J Manag Care Pharm 14:S2-14; quiz 15-6. 2008
    ....
  5. doi request reprint Using costs in cost-effectiveness models for chronic diseases: lessons from diabetes
    Thomas J Hoerger
    RTI UNC Center of Excellence in Health Promotion Economics, RTI International, Research Triangle Park, North Carolina 27709, USA
    Med Care 47:S21-7. 2009
    ..Cost-effectiveness models for chronic diseases frequently require simulating the development of disease complications over a long period. Model development often focuses on disease progression, with less attention devoted to costs...
  6. doi request reprint Improvements in risk factor control among persons with diabetes in the United States: evidence and implications for remaining life expectancy
    Thomas J Hoerger
    RTI International, Research Triangle Park, NC 27709, USA
    Diabetes Res Clin Pract 86:225-32. 2009
    ..S. adults with diagnosed diabetes between 1988-1994 and 2005-2006. We then project the impact of these changes on life expectancy and diabetes-related complications...
  7. doi request reprint A health policy model of CKD: 2. The cost-effectiveness of microalbuminuria screening
    Thomas J Hoerger
    RTI International, Research Triangle Park, NC 27709, USA
    Am J Kidney Dis 55:463-73. 2010
    ..Microalbuminuria screening may detect chronic kidney disease in its early stages, allowing for treatment that delays or prevents disease progression. The cost-effectiveness of microalbuminuria screening has not been determined...
  8. doi request reprint A health policy model of CKD: 1. Model construction, assumptions, and validation of health consequences
    Thomas J Hoerger
    RTI International, Research Triangle Park, NC 27709, USA
    Am J Kidney Dis 55:452-62. 2010
    ..A cost-effectiveness model that accurately represents disease progression, outcomes, and associated costs is necessary to evaluate the cost-effectiveness of interventions for chronic kidney disease (CKD)...
  9. pmc Cost-effectiveness of bariatric surgery for severely obese adults with diabetes
    Thomas J Hoerger
    RTI UNC Center of Excellence in Health Promotion Economics, RTI International, Research Triangle Park, North Carolina, USA
    Diabetes Care 33:1933-9. 2010
    ..To analyze the cost-effectiveness of bariatric surgery in severely obese (BMI >or=35 kg/m(2)) adults who have diabetes, using a validated diabetes cost-effectiveness model...
  10. pmc A cost-benefit analysis of lipid standardization in the United States
    Thomas J Hoerger
    RTI International, 3040 Cornwallis Road, PO Box 12194, Research Triangle Park, NC 27709, USA
    Prev Chronic Dis 8:A136. 2011
    ..The objective of this study was to estimate the benefits (ie, the value of reductions in heart disease deaths) and costs attributable to these lipid standardization programs...
  11. ncbi request reprint Cost-effectiveness of screening for pre-diabetes among overweight and obese U.S. adults
    Thomas J Hoerger
    Center of Excellence in Health Promotion Economics, RTI International, 3040 Cornwallis Rd, P O Box 12194, Research Triangle Park, NC 27709, USA
    Diabetes Care 30:2874-9. 2007
    ..To estimate the cost-effectiveness of screening overweight and obese individuals for pre-diabetes and then modifying their lifestyle based on the Diabetes Prevention Program (DPP)...
  12. ncbi request reprint Medicare's demonstration of competitive bidding for clinical laboratory services: what it means for clinical laboratories
    T J Hoerger
    Research Triangle Institute, Research Triangle Park, NC 27709 12194, USA
    Clin Chem 44:1728-34. 1998
    ..We close with some brief comments on how to succeed in competitive bidding for Medicare services...
  13. ncbi request reprint Cost effectiveness of pramipexole in Parkinson's disease in the US
    T J Hoerger
    Center for Economics Research, Research Triangle Institute, Research Triangle Park, North Carolina, USA
    Pharmacoeconomics 14:541-57. 1998
    ..The aim of this study was to estimate the costs and cost effectiveness (cost utility) of pramipexole compared with baseline treatment in patients with early and advanced PD...
  14. ncbi request reprint Medicare beneficiary satisfaction with durable medical equipment suppliers
    T J Hoerger
    Health Care Financ Rev 23:123-36. 2001
    ..Results of our analysis can be used as baseline estimates in evaluating CMS initiatives to reduce Medicare payments for DMEPOS...
  15. ncbi request reprint Screening for type 2 diabetes mellitus: a cost-effectiveness analysis
    Thomas J Hoerger
    RTI International, Research Triangle Park, North Carolina 27709, USA
    Ann Intern Med 140:689-99. 2004
    ..No randomized, controlled trial of screening for diabetes has been conducted. In the absence of direct evidence, cost-effectiveness models may provide guidance about preferred screening strategies...
  16. ncbi request reprint Optimal allocation of resources across four interventions for type 2 diabetes
    Stephanie R Earnshaw
    RTI Health Solutions, RTI, 3040 Cornwallis Road, P O Box 12194, Research Triangle Park, NC 27709, USA
    Med Decis Making 22:S80-91. 2002
    ..The interventions are intensive glycemic control, intensified hypertension control, cholesterol reduction, and smoking cessation...
  17. doi request reprint Individual and aggregate years-of-life-lost associated with overweight and obesity
    Eric A Finkelstein
    RTI International, Research Triangle Park, North Carolina, USA
    Obesity (Silver Spring) 18:333-9. 2010
    ..Unless something is done to reduce the rising prevalence of those with BMIs >35, or to mitigate the impact of obesity or its correlates on YLLs, expected life expectancy for US adults may decrease in the future...
  18. doi request reprint Forecasting age-related macular degeneration through the year 2050: the potential impact of new treatments
    David B Rein
    Research Triangle Institute International, Research Triangle Park, North Carolina, USA
    Arch Ophthalmol 127:533-40. 2009
    ..To forecast age-related macular degeneration (AMD) and its consequences in the United States through the year 2050 with different treatment scenarios...
  19. doi request reprint The cost-effectiveness of routine office-based identification and subsequent medical treatment of primary open-angle glaucoma in the United States
    David B Rein
    RTI International, Research Triangle Park, North Carolina
    Ophthalmology 116:823-32. 2009
    ..To estimate the incremental cost-effectiveness of routine glaucoma assessment and treatment under current eye care visit and treatment patterns and different levels of treatment effectiveness (from randomized trials)...
  20. pmc Comparing cost-of-illness estimates from alternative approaches: an application to diabetes
    Amanda A Honeycutt
    RTI International and RTI UNC Center of Excellence in Health Promotion Economics, 118 Beaufain Street, Charleston, SC 29401, USA
    Health Serv Res 44:303-20. 2009
    ..To compare disease cost estimates from two commonly used approaches...
  21. ncbi request reprint The economic burden of major adult visual disorders in the United States
    David B Rein
    RTI International, Research Triangle Park, NC, USA
    Arch Ophthalmol 124:1754-60. 2006
    ....
  22. ncbi request reprint Cost-effectiveness of osteoporosis screening and treatment with hormone replacement therapy, raloxifene, or alendronate
    Lee R Mobley
    Division for Health Services and Social Policy Research, RTI International Research Triangle Institute, 3040 Cornwallis Road, Research Triangle Park, NC 27709, USA
    Med Decis Making 26:194-206. 2006
    ..The authors conclude that screening and treating with alendronate are more cost-effective than screening and treating with raloxifene or HRT. Relative to an NST strategy, alendronate has a fairly good cost-effectiveness ratio...
  23. ncbi request reprint Cost-effectiveness of routine childhood vaccination for hepatitis A in the United States
    David B Rein
    RTI International, 2951 Flowers Rd, Suite 119, Atlanta, GA 30306, USA
    Pediatrics 119:e12-21. 2007
    ..We evaluated the economic impact of hepatitis A vaccination of all US children ages 12 to 23 months as compared with no vaccination and with current implementation of the preexisting (issued in 1999), regional policy...
  24. ncbi request reprint Cost-effectiveness of vitamin therapy for age-related macular degeneration
    David B Rein
    RTI International, Research Triangle Park, North Carolina, USA
    Ophthalmology 114:1319-26. 2007
    ..To determine the cost-effectiveness of vitamin therapy (antioxidants plus zinc) for all indicated patients diagnosed with age-related macular degeneration (AMD)...
  25. ncbi request reprint Technical appendix: cost-effectiveness of vitamin therapy for age-related macular degeneration
    David B Rein
    RTI International, Research Triangle Park, North Carolina 30341, USA
    Ophthalmology 114:e13-20. 2007
  26. ncbi request reprint A dynamic Markov model for forecasting diabetes prevalence in the United States through 2050
    Amanda A Honeycutt
    Research Triangle Institute, USA
    Health Care Manag Sci 6:155-64. 2003
    ..The projected number of people with diagnosed diabetes rises from 12.0 million in 2000 to 39.0 million in 2050, implying an increase in diagnosed diabetes prevalence from 4.4% in 2000 to 9.7% in 2050...
  27. pmc Use of econometric models to estimate expenditure shares
    Justin G Trogdon
    RTI International, 3040 Cornwallis Rd, PO Box 12194, Research Triangle Park, NC 27709 2194, USA
    Health Serv Res 43:1442-52. 2008
    ..To investigate the use of regression models to calculate disease-specific shares of medical expenditures...
  28. ncbi request reprint High-risk individuals' willingness to pay for diabetes risk-reduction programs
    F Reed Johnson
    RTI UNC Center for Excellence in Health Promotion Economics, RTI International, 3040 Cornwallis Road, P O Box 12194, Research Triangle Park, NC 27709, USA
    Diabetes Care 29:1351-6. 2006
    ..The purpose of this study was to estimate how much at-risk individuals are willing to pay for type 2 diabetes primary prevention programs...
  29. pmc The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance
    William H Herman
    University of Michigan Health System, Ann Arbor, Michigan, USA
    Ann Intern Med 142:323-32. 2005
    ..The Diabetes Prevention Program (DPP) demonstrated that interventions can delay or prevent the development of type 2 diabetes...
  30. ncbi request reprint An evaluation of cost sharing to finance a diet and physical activity intervention to prevent diabetes
    Ronald T Ackermann
    Department of Medicine, Indiana University School of Medicine, 250 University Blvd, Suite 122, Indianapolis, IN 46202, USA
    Diabetes Care 29:1237-41. 2006
    ..We explored whether this intervention could be offered in a way that allows return on investment for private health insurers while remaining attractive for consumers, employers, and Medicare...
  31. ncbi request reprint Managing people at high risk for diabetes
    William H Herman
    Ann Intern Med 144:66-7; author reply 67-8. 2006